Breathe Well Live Well
|
Global Market Research of Asthma and COPD Drug Market : An In-Depth Analysis …
Medgadget.com (blog) According to a recent market study published by Transparency Market Research (TMR), Everyone wants to breathe the air of freedom without any major hindrance or respiratory problem. However, in many cases, people suffer from breathing problems that … |
View full post on asthma – Google News
Fox News |
FDA experts endorse Teva's asthma drug, but reject use in key patient group
FierceBiotech An FDA advisory panel has handed Teva ($TEVA) a ringing endorsement for its IL-5 asthma drug reslizumab, offering a unanimous recommendation for marketing approval. That recommendation should quickly put it in direct rivalry with GlaxoSmithKline … FDA advisers recommend approval of Teva asthma drug in adults US FDA advisers recommend approval of Teva asthma drug for adults FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic Reslizumab |
View full post on asthma – Google News
Fox News |
FDA advisers recommend approval of Teva asthma drug in adults
Fox News An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's. The panel voted unanimously that the drug should not be approved for children aged 12 to 17. US FDA advisers recommend approval of Teva asthma drug for adults FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic Reslizumab |
View full post on asthma – Google News
|
STAT6 may explain mortality associated with some asthma drug
Baylor College of Medicine News (press release) The “black box” warning on some long-acting beta agonists – drugs used to ward off asthma attacks – mandates that such medications be sold as combination agents that contain a steroid to prevent the rare episodes of medication-associated deaths. |
View full post on asthma – Google News
Reuters |
US FDA advisers recommend approval of Teva asthma drug for adults
Reuters An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's <TEVA.TA) experimental drug reslizumab for severe asthma in patients aged 18 and older. Ad Comm tomorrow for Teva's asthma candidate reslizumab |
View full post on asthma – Google News
Market Realist |
FDA Will Review Teva's BLA for Asthma Drug Reslizumab
Market Realist Interleukin-5 is a key cytokine involved in the maturation, recruitment, and activation of eosinophils, which are inflammatory white blood cells implicated in a number of diseases, such as asthma. Elevated levels of blood eosinophils are a risk factor … |
View full post on asthma – Google News
Telegraph.co.uk |
Cat allergy group Circassia wins approval for asthma drug
Telegraph.co.uk Cat allergy group Circassia wins approval for asthma drug. The inhaler will soon be available to European consumers as a generic alternative to rival a treatment already on the market from GlaxoSmithKline. Grumpycat. Circassia is developing a novel … Industry NewsCircassia wins EU asthma product approval Circassia wins EU regulatory boost for asthma generic drug Circassia Pharma gets UK approval for asthma challenger |
View full post on asthma – Google News
|
Asthma and COPD Drug Market expected to reach USD 26965.5 million in 2017
Medgadget.com (blog) According to a recent market study published by Transparency Market Research (TMR), the global asthma and COPD market was worth USD 25,102.3 million in 2010, which is expected to reach USD 26,965.5 million in 2017 along with a CAGR figure of … |
View full post on asthma – Google News
ETHealthWorld.com |
Ajanta Pharma launches generic asthma drug in US market
ETHealthWorld.com New Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, … Ajanta Pharma launches generic asthma drug in US market; shares up over 2% |
View full post on asthma – Google News
|
Ajanta Pharma Launches Generic Asthma Drug in US Market
NDTV New Delhi: Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, … |
View full post on asthma – Google News